Eupraxia Pharmaceuticals ... (EPRX)
3.60
-0.34 (-8.53%)
At close: Mar 04, 2025, 11:10 AM
Eupraxia Pharmaceuticals Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| Cash & Equivalents | 25.5M | 24.74M | 20.89M | 150.13K | 1.16M | 823.48K | 3.99M |
| Short-Term Investments | -6.16M | n/a | 9.01M | n/a | n/a | n/a | n/a |
| Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | 9.1K | 3.37K | 31.37K | n/a | n/a | n/a | n/a |
| Receivables | 190.61K | n/a | 337.03K | 486.69K | 1.03M | 1.09M | 1.04M |
| Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 270.71K | 235.9K | 483.52K | 655.74K | 237.43K | 289.17K | 216.9K |
| Total Current Assets | 19.8M | 25.18M | 30.6M | 1.14M | 2.64M | 2.47M | 5.42M |
| Property-Plant & Equipment | 601.61K | 695.48K | 589.07K | 315.34K | 646.21K | 435.47K | 419.44K |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 610.71K | 698.85K | 620.44K | 315.34K | 646.21K | 435.47K | 419.44K |
| Total Assets | 26.72M | 25.88M | 31.22M | 1.45M | 3.29M | 2.91M | 5.84M |
| Account Payables | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Short-Term Debt | 13.83M | 129.82K | 121.41K | 12.56M | 11.67M | 3.8M | 5.84K |
| Other Current Liabilities | 11.67M | 4.01M | 2.15M | 9.98M | 8.99M | 10.55M | 724.84K |
| Total Current Liabilities | 25.55M | 4.14M | 2.27M | 22.54M | 20.67M | 14.34M | 730.68K |
| Long-Term Debt | n/a | 12.04M | 9.37M | 155.8K | 251.19K | n/a | 4.08K |
| Other Long-Term Liabilities | n/a | -1.67M | 29.71K | 419.18K | 498.15K | n/a | 1.05K |
| Total Long-Term Liabilities | n/a | 10.37M | 9.4M | 574.97K | 749.35K | n/a | 5.13K |
| Total Liabilities | 25.55M | 14.51M | 11.67M | 23.12M | 21.42M | 14.34M | 735.82K |
| Total Debt | 10.45M | 10.55M | 9.56M | 12.77M | 11.94M | 3.79M | 12.47K |
| Common Stock | 92.91M | 92.34M | 80.71M | 23.8M | 23.55M | 23.55M | 23.59M |
| Retained Earnings | -105.5M | -97.45M | -74.19M | -51.2M | -47.2M | -40.02M | -20.11M |
| Comprehensive Income | -3.59M | -2.79M | 16.56M | -0.00 | n/a | n/a | n/a |
| Shareholders Equity | 2.22M | 12.86M | 20.39M | -21.21M | -17.69M | -11.06M | 5.98M |
| Total Investments | -6.16M | n/a | 9.01M | n/a | n/a | n/a | n/a |